+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Nanostructured transdermal hormone replacement therapy for relieving menopausal symptoms: a confocal Raman spectroscopy study

Nanostructured transdermal hormone replacement therapy for relieving menopausal symptoms: a confocal Raman spectroscopy study

Clinics 69(2): 75-82

To determine the safety and efficacy of a transdermal nanostructured formulation of progesterone (10%) combined with estriol (0.1%) + estradiol (0.25%) for relieving postmenopausal symptoms. A total of 66 postmenopausal Brazilian women with climacteric symptoms of natural menopause received transdermal nanostructured formulations of progesterone and estrogens in the forearm daily for 60 months to mimic the normal ovarian secretory pattern. Confocal Raman spectroscopy of hormones in skin layers was performed. Clinical parameters, serum concentrations of estradiol and follicle-stimulating hormone, blood pressure, BI-RADS classification from bilateral mammography, and symptomatic relief were compared between baseline and 60 months post-treatment. Clinicaltrials.gov: NCT02033512. An improvement in climacteric symptoms was reported in 92.5% of women evaluated before and after 60 months of treatment. The serum concentrations of estradiol and follicle-stimulating hormone changed significantly (p<0.05) after treatment; the values of serum follicle-stimulating hormone decreased after 60 months from 82.04±4.9 to 57.12±4.1 IU/mL. A bilateral mammography assessment of the breasts revealed normal results in all women. No adverse health-related events were attributed to this hormone replacement therapy protocol. The nanostructured formulation is safe and effective in re-establishing optimal serum levels of estradiol and follicle-stimulating hormone and relieving the symptoms of menopause. This transdermal hormone replacement therapy may alleviate climacteric symptoms in postmenopausal women.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 054545976

Download citation: RISBibTeXText

PMID: 24519196

DOI: 10.6061/clinics/2014(02)01

Related references

Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. Journal of Clinical Endocrinology and Metabolism 84(12): 4559-4565, 1999

Hormone replacement therapy with 17 beta-estradiol dydrogesterone: results of a 3-month open-label study. Wiener Klinische Wochenschrift 111(24): 1035-1043, 1999

Comparison of Albicans ID2 agar plate with the germ tube for presumptive identification of Candida albicans. Diagnostic Microbiology and Infectious Disease 42(3): 181-185, 2002

Compliance with hormone replacement therapy in Thai women. Maturitas 44(3): 201-205, 2003

Menopausal symptoms and health problems of women aged 50-65 years in southern Jordan. Climacteric 9(4): 305-311, 2006

Hormone replacement therapy for internal risk patients. Gynakologisch-Geburtshilfliche Rundschau 46(4): 174-190, 2006

CAPiTA: The urine antigen detection (SSUAD) was not validated for PCV13 vaccinated patients. Vaccine 35(51): 7077, 2017

Pilot study of gemtuzumab ozogamicin, liposomal daunorubicin, cytarabine and cyclosporine regimen in patients with refractory acute myelogenous leukemia. Leukemia Research 27(10): 887-891, 2003

A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan. Scandinavian Journal of Infectious Diseases 36(5): 372-379, 2004

Effect of oral and parenteral administration of metanil yellow on some hepatic and intestinal biochemical parameters. Journal of Applied Toxicology 17(1): 85-91, 1997

Hormone replacement therapy for men: has the time come?. Geriatrics 50(10): 52, 1995

Menopausal status, hormone replacement therapy use and risk of self-reported physician-diagnosed osteoarthritis in women attending menopause clinics in Italy. Maturitas 46(3): 207-212, 2003

Prescribing habits of general practitioners in choosing an empirical antibiotic regimen for lower respiratory tract infections in adults in Sicily. Pharmacological Research 40(1): 47-52, 1999

The effectiveness of helmeted guineafowl Numida meleagris (Linnaeus 1766) in controlling the banded fruit weevil Phlyctinus callosus (Schoenherr 1826), and their impact on other invertebrates. Agriculture Ecosystems and Environment 55(3): 169-179, 1995

The effects of surgical marking dyes upon estrogen receptor enzyme immunoassay and progesterone receptor enzyme immunoassay results. Breast Cancer Research and Treatment 46(1): 42, 1997